170367 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates Assays involving proteins of known structure or function as defined in the subgroups
Sub-classes:MARKERS FOR THE DIAGNOSIS AND TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED LIVER FIBROSIS
#2METHOD FOR ANALYZING A TUMOR-SPECIFIC MARKER
#3ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#4Tumor Antigens for Determining Cancer Therapy
#5MOLECULAR PROFILING OF TUMORS
#6ANTI-PVRIG ANTIBODIES AND METHODS OF USE
#7PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MALIGNANT BREAST CANCER
#8ANTIBODY SEQUENCES OF THREE ANTIBODY CANDIDATES TARGETING HUMAN LYMPHOCYTE ANTIGEN 6 FAMILY MEMBER K (LY6K)
#9PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS
#10MOLECULAR PROFILING OF TUMORS
#11THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES
#12METHODS FOR DETECTING AND TREATING CEREBRAL CAVERNOUS MALFORMATION
#13METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT’S RECOVERY FROM A BRAIN INJURY
#14ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#15TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#16IMPROVED METHODS AND DEVICES FOR ACCURATE DIAGNOSIS OF INFECTIONS
#17RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I
#18USE OF MARKERS INCLUDING FILAMIN A IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#19METHODS OF IDENTIFYING SUBJECTS RESPONSIVE TO TREATMENT FOR AN AUTOIMMUNE DISEASE AND COMPOSITIONS FOR TREATING THE SAME
#20REAGENT KIT, MEASUREMENT KIT, AND MEASUREMENT METHOD
#21ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU
#22Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
#23METHODS FOR AIDING IN THE DIAGNOSIS AND EVALUATION OF A SUBJECT WHO HAS SUSTAINED AN ORTHOPEDIC INJURY AND THAT HAS OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD, SUCH AS MILD TRAUMATIC BRAIN INJURY (TBI), USING GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND/OR UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1)
#24HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#25ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS
#26NON-INVASIVE MONITORING OF LIVER DISEASE TREATMENT
#27GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS
#28PANCREATIC CANCER DETECTION
#29FILAMIN A BINDING PROTEINS AND USES THEREOF
#30METHOD AND COMPOSITIONS FOR DETECTING AN ADENOMA-ADENOCARCINOMA TRANSITION IN CANCER
#31NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#32NANOBODY FUNCTIONALIZED ELECTROCHEMICAL TRANSISTORS AND METHODS OF MAKING AND USING THEREOF
#33IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#34STRUCTURAL-PROFILING OF ANALYTES BY NANOPORE TRAPPING
#35PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS
#36METHOD FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS (PBC) USING NOVEL AUTOANTIGENS
#37DIAGNOSTIC METHODS FOR LIVER DISORDERS
#38PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
#39Anti-PVRIG antibodies and methods of use
#40Highly Sensitive System and Method for Analysis of Troponin
#41Methods and Compositions for Targeting Polyubiquitin
#42BLOOD BIOMARKER THAT PREDICTS PERSISTENT COGNITIVE DYSFUNCTION AFTER CONCUSSION
#43Tumor Antigens for Determining Cancer Therapy
#44NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#45Tau Immunotherapy
#46NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#47METHODS AND SYSTEMS OF DIAGNOSING BRAIN INJURY
#48PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#49PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#50PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#51NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#52MARKERS FOR THE DIAGNOSIS AND TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCE LIVER FIBROSIS
#53Anti-tumour response to modified self-epitopes
#54METHOD OF ISOLATING CIRCULATING TUMOR CELLS
#55METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY
#56NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#57MOLECULAR PROFILING OF TUMORS
#58NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#59T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3
#60NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#61NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#62NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#63Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#64Compositions and methods for modulating kinase activity
#65METHOD FOR ASSAYING LOWER RESPIRATORY TRACT INFECTION OR INFLAMMATION
#66METHOD FOR DETECTING TUMOR CELL SURFACE MARKER MOLECULE PD-L1
#67PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY
#68YKL-40-TARGETING HUMAN MONOCLONAL ANTIBODY
#69ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#70DETECTION OF DYSTROGLYCAN
#71Peptides and combination of peptides for use in immunotherapy against various cancers
#72Peptides and combination of peptides for use in immunotherapy against various cancers
#73Peptides and combination of peptides for use in immunotherapy against various cancers
#74Peptides and combination of peptides for use in immunotherapy against various cancers
#75Peptides and combination of peptides for use in immunotherapy against various cancers
#76Peptides and combination of peptides for use in immunotherapy against various cancers
#77Peptides and combination of peptides for use in immunotherapy against various cancers
#78Biomarkers of fast progression of chronic kidney disease
#79MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#80Peptides and combination of peptides for use in immunotherapy against various cancers
#81METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT'S RECOVERY FROM A BRAIN INJURY
#82METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT'S RECOVERY FROM A BRAIN INJURY
#83DETECTION OF DESMOGLEIN-2 IN CANCERS OF EPITHELIAL ORIGIN
#84Peptides and combination of peptides for use in immunotherapy against various tumors
#85MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
#86PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS
#87DETECTION OF MISFOLDED TAU PROTEIN
#88MARKERS AND THEIR USE IN BRAIN INJURY
#89METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#90Method and kit for discriminating between parkinson's disease and multiple system atrophy
#91METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
#9214-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#93Gene expression markers and treatment of multiple sclerosis
#94BH4 Stabilized Peptides And Uses Thereof
#95DIAGNOSING AND TREATING ALZHEIMERS DISEASE
#96Peptides and combination of peptides for use in immunotherapy against various tumors
#97Peptides and combination of peptides for use in immunotherapy against various tumors
#98Peptides and combination of peptides for use in immunotherapy against various tumors
#99Therapeutic and diagnostic methods and compositions for neurodegenerative diseases
#100Peptides and combination of peptides for use in immunotherapy against various tumors
#101Peptides and combination of peptides for use in immunotherapy against various tumors
#102Peptides and combination of peptides for use in immunotherapy against various tumors
#103Peptides and combination of peptides for use in immunotherapy against various tumors
#104Peptides and combination of peptides for use in immunotherapy against various tumors
#105MONOCLONAL ANTIBODIES AGAINST LORICRIN
#106Peptides and combination of peptides for use in immunotherapy against various tumors
#107Peptides and combination of peptides for use in immunotherapy against various tumors
#108Peptides and combination of peptides for use in immunotherapy against various tumors
#109Peptides and combination of peptides for use in immunotherapy against various tumors
#110Peptides and combination of peptides for use in immunotherapy against various tumors
#111Compositions and methods for detection of SMN protein in a subject and treatment of a subject
#112Methods and materials for identifying and treating cancers having elevated levels of phosphorylated ubiquitin
#113NMES1 ANTIBODIES AND METHODS OF USE THEREOF
#114Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
#115Peptides and combination of peptides for use in immunotherapy against various cancers
#116DETECTION OF AUTOREACTIVE FECAL IMMUNOGLOBULIN A (IGA) FOR DIAGNOSIS OF LUPUS
#117Peptides and combination of peptides for use in immunotherapy against various cancers
#118Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#119ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF
#120Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
#121Peptides and combination of peptides for use in immunotherapy against various cancers
#122Peptides and combination of peptides for use in immunotherapy against various cancers
#123Protein biomarkers for diseases associated with the contact activation system
#124Peptides and combination of peptides for use in immunotherapy against various cancers
#125Method and compositions for detecting an adenoma-adenocarcinoma transition in cancer
#126COMPOSITIONS AND METHODS FOR ASSESSING TOXICITY USING DYNAMIC BH3 PROFILING
#127Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
#128LEUKOCYTE RECRUITMENT IN INFECTIOUS DISEASE
#129METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#130ENZYME COUPLED ASSAY FOR QUANTIFICATION OF PROTEIN AND PEPTIDE BINDING BY SAMDI MASS SPECTROMETRY
#131Anti-Tumour Response to Modified Self-Epitopes
#132Anti-PVRIG antibodies and methods of use
#133Peptides and combination of peptides for use in immunotherapy against various tumors
#134IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#135PHARMACEUTICAL USE OF ACTININ-4 INVOLVED IN INDUCTION OF CERVICAL CANCER
#136INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
#137Filamin A binding proteins and uses thereof
#138METHODS AND ASSAYS RELATING TO CIRCULATING TUMOR CELLS
#139ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS
#140Disease detection method
#141Methods and compositions for targeting polyubiquitin
#142Method of treating and prognosing scoliotic patient subgroups
#143METHODS AND DEVICES FOR ACCURATE DIAGNOSIS OF INFECTIONS
#144HEAT SHOCK PROTEIN (HSP) INHIBITION AND MONITORING EFFECTIVENESS THEREOF
#145Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
#146NMR measurements of NMR biomarker GlycA
#147METHODS FOR PREDICTING OUTCOMES AND TREATING COLORECTAL CANCER USING A CELL ATLAS
#148High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
#149METHODS FOR DOSING AN ACTIVIN-ACTRIIA ANTAGONIST AND MONITORING OF TREATED PATIENTS
#150METHOD FOR DETECTING AN ANTIGEN-SPECIFIC ANTIBODY AND REAGENT FOR USE THEREIN
#151METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#152REAGENT KIT, MEASUREMENT KIT, AND MEASUREMENT METHOD
#153Method for isolating cell nuclei having enhanced antigenicity from fixed cells or FFPE tissue section, and antigen activator and kit therefor
#154Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#155Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides
#156Human-derived anti-huntingtin (HTT) antibodies and uses thereof
#157BENZENESULFONAMIDE DERIVATIVES OF QUINOXALINE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN METHODS FOR TREATING CANCER
#158ENZYME COUPLED ASSAY FOR QUANTIFICATION OF PROTEIN AND PEPTIDE BINDING BY SAMDI MASS SPECTROMETRY
#159Histone anti-cancer vaccines
#160Diagnosing and treating Alzheimer's disease
#161METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
#162EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE
#163Highly Sensitive System and Method for Analysis of Troponin
#164USE OF MARKERS INCLUDING FILAMIN A IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#165Peptides and combination of peptides for use in immunotherapy against various tumors
#166Urea biosensors and uses thereof
#167Peptides and combination of peptides for use in immunotherapy against various tumors
#168METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT
#169Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-Synuclein
#170Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#171TREATMENTS AND DIAGNOSTICS FOR CANCERS
#172Anti-transthyretin antibodies
#173Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#174T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3
#175HUMAN ANTI-TAU ANTIBODIES
#176Methods for treating, preventing and predicting risk of developing breast cancer
#177Podocan as a Predictive Biomarker of Cardiovascular Events
#178HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#179Substituted heterocycles for targeting Hsp90
#180GP2 isoforms and their use in autoantibody capture
#181PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
#182ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY
#183Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#18414-3-3 Antagonists for the Prevention and Treatment of Arthritis
#185Anti-PVRIG antibodies and methods of use
#186Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
#187Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury
#188Tau immunotherapy
#189METHODS OF CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMA
#190Biosensor and application of the same
#191MARKERS AND THEIR USE IN BRAIN INJURY
#192BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#193Peptides and combination of peptides for use in immunotherapy against various cancers
#194Relaxin1 derived peptides for use in immunotherapy
#195METHODS APPARATUSES AND SYSTEMS FOR DETECTING AND QUANTIFYING PHOSPHOPROTEINS
#196Use of IGFBP-7 in the assessment of heart failure
#197DIAGNOSTIC METHODS FOR LIVER DISORDERS
#198Mutant calreticulin for the diagnosis of myeloid malignancies
#199Peptides and combination of peptides for use in immunotherapy against various tumors
#200Peptides and combination of peptides for use in immunotherapy against various tumors
#201Peptides and combination of peptides for use in immunotherapy against various tumors
#202Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
#203TDP-43 specific binding molecules
#204MOLECULAR PROFILING OF TUMORS
#205Peptides and combination of peptides for use in immunotherapy against various cancers
#206Functionalized eyewear device for detecting biomarker in tears
#207Osteocalcin as a treatment for cognitive disorders
#208Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
#209METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN
#210FREE NGAL AS A BIOMARKER FOR CANCER
#211Immuno-based retargeted endopeptidase activity assays
#212Novel Biomarkers for Sub-Typing Pancreatic Ductal Adenocarcinoma
#213Methods for treating cancer in patients with elevated levels of Bim
#214Anti-GP73 monoclonal antibodies and methods of obtaining the same
#215Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#216Methods for quantitation of insulin levels by mass spectrometry
#217Peptides and combination of peptides for use in immunotherapy against various tumors
#218Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#219IGFBP7 for diagnosing diastolic dysfunction
#220Disease biomarkers and treatment methods related thereto
#221Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases
#222PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS
#223Peptides and combination of peptides for use in immunotherapy against various cancers
#224Methods for detecting cardiac damage
#225USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER
#226Peptides and combination of peptides for use in immunotherapy against various cancers
#227Redox-based reagents for methionine bioconjugation
#228PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#229DIFFERENTIAL BH3 MITOCHONDRIAL PROFILING
#230COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#231Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
#232Methods of diagnosing endometriosis
#233Anti-tau antibodies
#234Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
#235α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#236Tumor antigens for determining cancer therapy
#237NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#238Alzheimer's disease animal model
#239Diagnosing and treating Alzheimer's disease
#240MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS
#241Profiling peptides and methods for sensitivity profiling
#242SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein
#243Method of treating extracellular tissue and vascular calcification and arteriosclerosis
#244HDAC1,2 inhibitors and methods of using the same
#245Marker for statin treatment stratification in heart failure
#246Thyroglobulin quantitation by mass spectroscopy
#247NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#248Peptides and combination of peptides for use in immunotherapy against various tumors
#249Use Of Wiskott-Aldrich Syndrome Protein (WASP) As A Biological Marker And In Vitro Method For Monitoring The Progression Of A Hematological Disease
#250Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor
#251Method of isolating circulating tumor cells
#252BH4 stabilized peptides and uses thereof
#253Method of testing for pulmonary hypertension
#254Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#255METHOD FOR EARLY DIAGNOSING AND TREATING ACUTE CORONARY SYNDROME
#256Detection of cancer by elevated levels of bcl-2
#257METHODS TO DETECT NON-GENOTOXIC CARCINOGENS USING FLATWORMS
#258Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#259Method for detecting an analyte using surface enhanced Raman spectroscopy
#260Multiplex MRM assay for evaluation of cancer
#261Substituted heterocycles for targeting HSP90
#262Methods and compositions for targeting polyubiquitin
#263Peptides and combination of peptides for use in immunotherapy against various tumors
#264Peptides and combination of peptides for use in immunotherapy against various cancers
#265Peptides and combination of peptides for use in immunotherapy against various tumors
#266Method to predict response to pharmacological chaperone treatment of diseases
#267LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#268DIAGNOSTIC KIT FOR CENTRAL NERVOUS SYSTEM AFFLICTIONS
#269csPCNA Isoform Antibodies And Uses Thereof
#270Peptides and combination of peptides for use in immunotherapy against various cancers
#271Peptides and combination of peptides for use in immunotherapy against various cancers
#272Anti-alpha synuclein binding molecules
#273Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
#274Peptides and combination of peptides for use in immunotherapy against various tumors
#275ANTI-TUMOUR RESPONSE TO MODIFIED SELF-EPITOPES
#276IMiD screening methods IMiD-sensitive cells with mutant CRBN
#277Peptides and combination of peptides for use in immunotherapy against various tumors
#278Detection of misfolded tau protein
#279NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#280NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE
#281TPM4-ALK fusion protein and composition for diagnosing cancer
#282Solid Phase Assay for Detecting Biomarkers for Cardiodiabetes
#283Profiling peptides and methods for sensitivity profiling
#284DIAGNOSIS OF A NOVEL AUTOIMMUNE DISEASE
#285Therapeutic and diagnostic methods and compositions for neurodegenerative diseases
#286Treatments and diagnostics for cancers
#287Nuclear stress response in motor neuron disease and other neurological diseases
#288COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#289Markers for inflammatory bowel disease
#290METHODS AND DEVICES FOR DETECTING PROTEIN IN SALIVA SAMPLES
#291Method for assaying lower respiratory tract infection or inflammation
#292Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications
#293Multiple hybrid immunoassay
#294RELAXIN1 derived peptides for use in immunotherapy against various tumors
#295Microparticle fractionation
#296SYSTEM AND METHODS FOR THE DETECTION OF BIOMARKERS OF NEURODEGENERATIVE DISORDERS
#297MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#298Peptides and combination of peptides for use in immunotherapy against various tumors
#299NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#300Diagnosing and treating Alzheimers disease